The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-tumor activity of BH-30643, a novel macrocyclic kinase inhibitor, in EGFR-mutant lung cancer models.
 
Wei Deng
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Dayong Zhai
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Ping Jiang
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Nancy Ling
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Yue Hu
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Zhenping Wang
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Danan Li
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Joshua Choi
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Eugene Rui
Employment - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics
 
Geoff Oxnard
Employment - Foundation Medicine; LOXO at Lilly
Stock and Other Ownership Interests - Lilly; Roche
 
Xiuning Le
Consulting or Advisory Role - Abbvie; ABION; Allyst; ArriVent Biopharma; ArriVent Biopharma; AstraZeneca; Aviston; Bayer; Black Diamond Therapeutics; BlossomHill Therapeutics; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo/Lilly; EMD Serono; Hengrui Therapeutics; Janssen Oncology; Lilly; Merus; Novartis; PineTree; Regeneron; Spectrum Pharmaceuticals; Systimmune; Taiho Pharmaceutical
Research Funding - ArriVent Biopharma (Inst); Boehringer Ingelheim (Inst); EMD Serono (Inst); Janssen (Inst); Lilly (Inst); Regeneron (Inst); Teligene (Inst)
Travel, Accommodations, Expenses - EMD Serono; Johnson & Johnson/Janssen; Regeneron; Spectrum Pharmaceuticals
 
Sai-Hong Ou
Stock and Other Ownership Interests - BloosomHill therapeutics; Lilly; MBrace Therapeutics; Nuvalent, Inc.; Nuvation Bio
Consulting or Advisory Role - Anheart Therapeutics; Avistone; Bayer; Innovent Biologics; Pfizer
Research Funding - AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); BMS; Janssen (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche Pharma AG (Inst)
 
J. Jean Cui
Employment - BlossomHill Therapeutics
Leadership - BlossomHill Therapeutics
Stock and Other Ownership Interests - BlossomHill Therapeutics